Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test the effectiveness of high dose radiation administered by both proton and photon therapy. Radiation is an effective treatment for many types of tumors and it is thought that radiation alone, when given in much higher doses over a shorter period of time, may be more effective in controlling recurrence of sarcoma.


Clinical Trial Description

- In this study three types of radiation will be used: standard radiation (called photon); alternative form of radiation called proton beam therapy; and a localized radiation applicator plaque that can be applied to the surface of the dura (the fibrous outer envelope that surrounds the spinal cord and fluid surrounding the spinal cord) at time of surgical removal of the tumor.

- Radiation treatments (photon and proton) and possibly surgical removal of portions of the tumor with intraoperative radiation delivery to the surface dura with intraoperative radiation delivery will be performed over a period of 12 weeks. As part of the treatment planning process, participants will need two treatment planning CT scans and 2-3 treatment planning sessions.

- Participants will receive, in total, 39-43 photon/proton treatments. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00592345
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Completed
Phase Phase 1/Phase 2
Start date May 1999
Completion date March 2016

See also
  Status Clinical Trial Phase
Completed NCT00815945 - Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors Phase 2
Recruiting NCT01524016 - 68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia Early Phase 1
Withdrawn NCT02766842 - Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) Phase 2